CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Cleveland, Ohio, United States and 18 other locations
The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to pl...
Phase 3
Kent, Ohio, United States and 226 other locations
Diabetic Retinopathy (DR) is a common eye condition caused by diabetes, where high blood sugar levels damage the blood vessels in t...
Phase 2, Phase 3
Beachwood, Ohio, United States and 36 other locations
This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple a...
Phase 1, Phase 2
Cleveland, Ohio, United States and 46 other locations
The primary objective of this study is to demonstrate that ribupatide (KAI-9531) subcutaneous (SC) injection once weekly is superior to placebo on:*...
Phase 3
Cleveland, Ohio, United States and 172 other locations
Periodontitis is a prevalent chronic inflammatory disease that exacerbates systemic inflammation and poses challenges for glycemic control in diabetic...
Early Phase 1
Cleveland, Ohio, United States
Study ASC30-302 (AURORA-2) is a Phase III, global, multicenter, randomized, double-blind, placebo-controlled study to investigate the long-term effic...
Phase 3
Cleveland, Ohio, United States and 134 other locations
This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...
Phase 3
Cleveland, Ohio, United States and 78 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Mentor, Ohio, United States and 229 other locations
This is a randomized, masked, active-controlled, parallel-group, multi-center study that will assess the efficacy of ILUVIEN as a baseline therapy in...
Phase 4
Cleveland, Ohio, United States and 39 other locations
Clinical trials
Research sites
Resources
Legal